FamiCord/€V3V
1D1W1MYTD1Y5YMAX
Capital at risk
About FamiCord
Vita 34 AG, founded in 1997 and headquartered in Leipzig, Germany, specializes in the collection, processing, and long-term storage of stem cells from umbilical cord blood and tissue. The company offers cryopreservation services, enabling the storage of perinatal tissues for potential future medical therapies. Following its merger with PBKM, Vita 34 has expanded its focus to include investments in cell and gene therapies, as well as contract development and manufacturing organization (CDMO) services. Operating in approximately 50 countries, the company has stored around one million units of biological material. In 2023, Vita 34 reported revenues of €77.1 million, marking an 11.8% increase from the previous year.
- Ticker
- €V3V
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 684
- Headquarters
- Leipzig, Germany
- Website
- www.famicord.com
FamiCord Metrics
BasicAdvanced
€51M
-
-€0.43
0.62
-
Price and volume
Market cap
€51M
Beta
0.62
52-week high
€7.45
52-week low
€2.62
Average daily volume
1.1K
Financial strength
Current ratio
0.694
Quick ratio
0.642
Long term debt to equity
5.502
Total debt to equity
6.858
Interest coverage (TTM)
1.46%
Profitability
EBITDA (TTM)
6.914
Gross margin (TTM)
56.95%
Net profit margin (TTM)
-8.57%
Operating margin (TTM)
2.05%
Effective tax rate (TTM)
-33.35%
Revenue per employee (TTM)
€130,000
Management effectiveness
Return on assets (TTM)
0.70%
Return on equity (TTM)
-90.96%
Valuation
Price to revenue (TTM)
0.585
Price to book
10.14
Price to tangible book (TTM)
-1.26
Price to free cash flow (TTM)
14.007
Free cash flow yield (TTM)
7.14%
Free cash flow per share (TTM)
0.21
Growth
Revenue change (TTM)
0.06%
Earnings per share change (TTM)
-28.52%
3-year revenue growth (CAGR)
6.29%
10-year revenue growth (CAGR)
18.73%
3-year earnings per share growth (CAGR)
-33.59%
10-year earnings per share growth (CAGR)
-1.45%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.